Anna Vidal-Crespo, Vanina Rodriguez, Alba Matas-Cespedes, Eriong Lee, Alfredo Rivas-Delgado, Eva Giné, Alba Navarro, Sílvia Beà, Elias Campo, Armando López-Guillermo, Monica Lopez-Guerra, Gaël Roué, Dolors Colomer, Patricia Pérez-Galán. The Bruton tyrosine kinase inhibitor CC-292 shows activity in mantle cell lymphoma and synergizes with lenalidomide and NIK inhibitors depending on nuclear factor-κB mutational status. Haematologica 2017;102(11):e447-e451; https://doi.org/10.3324/haematol.2017.168930.